{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:16:23Z","timestamp":1791162983834,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ymgme.2012.05.003","type":"journal-article","created":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T03:47:56Z","timestamp":1336967276000},"page":"395-402","source":"Crossref","is-referenced-by-count":34,"title":["Biomarkers for the mucopolysaccharidoses: Discovery and clinical utility"],"prefix":"10.1016","volume":"106","author":[{"given":"Lorne A.","family":"Clarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Winchester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tylki-Szyma\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernan","family":"Amartino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2012.05.003_bb0390","article-title":"Predictive genomic biomarkers","author":"Kumar","year":"2011","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0395","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgme.2012.05.003_bb0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10545-011-9308-6","article-title":"Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies","volume":"34","author":"Aerts","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10545-005-5673-3","article-title":"Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses","volume":"28","author":"Tomatsu","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0025","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10545-005-0069-y","article-title":"Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses","volume":"28","author":"Tomatsu","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0030","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1002\/ajmg.a.32294","article-title":"Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression","volume":"146A","author":"Munoz-Rojas","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2012.05.003_bb0035","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.cellbio.22.010605.093433","article-title":"The molecular diversity of glycosaminoglycans shapes animal development","volume":"22","author":"B\u00fclow","year":"2006","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fj.05-4682rev","article-title":"Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation","volume":"20","author":"Taylor","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0045","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1017\/S1462399408000550","article-title":"The mucopolysaccharidoses: a success of molecular medicine","volume":"10","author":"Clarke","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0050","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/nature05817","article-title":"Heparan sulphate proteoglycans fine-tune mammalian physiology","volume":"446","author":"Bishop","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2012.05.003_bb0055","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/j.1600-0854.2009.00987.x","article-title":"Glycosaminoglycan chains affect exocytic and endocytic protein traffic","volume":"10","author":"Kobialka","year":"2009","journal-title":"Traffic"},{"key":"10.1016\/j.ymgme.2012.05.003_bb0060","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4161\/auto.5.2.7390","article-title":"Self-eating in skeletal development: implications for lysosomal storage disorders","volume":"5","author":"Settembre","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.ymgme.2012.05.003_bb0065","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1074\/jbc.M110.192062","article-title":"Secondary storage of dermatan sulfate in Sanfilippo disease","volume":"286","author":"Lamanna","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0070","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbamcr.2008.11.014","article-title":"Secondary lipid accumulation in lysosomal disease","volume":"1793","author":"Walkley","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2012.05.003_bb0075","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1042\/BST0381442","article-title":"Storage problems in lysosomal diseases","volume":"38","author":"Heard","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0080","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/clinchem\/37.4.572","article-title":"The spot test is not a reliable screening procedure for mucopolysaccharidoses","volume":"37","author":"de Jong","year":"1991","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0085","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0378-4347(00)83875-X","article-title":"Methods for analysis of urinary glycosaminoglycans","volume":"429","author":"Kodama","year":"1988","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0090","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/mas.20200","article-title":"On-line separations combined with MS for analysis of glycosaminoglycans","volume":"28","author":"Zaia","year":"2009","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2010.09.003","article-title":"Efficient analysis of urinary glycosaminoglycans by LC-MS\/MS in mucopolysaccharidoses type I, II and VI","volume":"102","author":"Auray-Blais","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0100","doi-asserted-by":"crossref","first-page":"37515","DOI":"10.1074\/jbc.M111.287474","article-title":"Mucopolysaccharidosis type I, unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking \u03b1-l-iduronidase","volume":"286","author":"Holley","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/mgme.1998.2761","article-title":"Glycosaminoglycan accumulation and excretion in the mucopolysaccharidosis: characterization and basis of diagnostic test for MPS","volume":"65","author":"Byers","year":"1998","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I","volume":"123","author":"Clarke","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2012.05.003_bb0115","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome) [published correction appears in Genet Med 9 (2006) 599]","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0120","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","volume":"148","author":"Harmatz","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/GIM.0b013e3181fea459","article-title":"Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/GIM.0b013e318206786f","article-title":"Idursulfase treatment of Hunter syndrome in children younger than 6 years: results from the Hunter Outcome Survey","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10545-010-9215-2","article-title":"Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II","volume":"34","author":"Schulze-Frenking","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0140","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1542\/peds.2006-2156","article-title":"Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-l-iduronidase (laronidase)","volume":"120","author":"Wraith","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2012.05.003_bb0145","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jpeds.2008.11.005","article-title":"Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy","volume":"154","author":"Wynn","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.bmt.1705569","article-title":"Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease","volume":"39","author":"Church","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1651-2227.2007.00212.x","article-title":"A clinical study of 77 patients with mucopolysaccharidosis type II","volume":"96","author":"Schwartz","year":"2007","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0160","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.a.30579","article-title":"Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux\u2013Lamy syndrome)","volume":"134A","author":"Swiedler","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2012.05.003_bb0165","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0188-4409(00)00104-1","article-title":"Urinary glycosaminoglycan excretion in healthy subjects and in patients with mucopolysaccharidoses","volume":"31","author":"Gallegos-Arreola","year":"2000","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02725652","article-title":"Diagnosis of mucopolysaccharidoses: how to avoid false positives and false negatives","volume":"71","author":"Mahalingam","year":"2004","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0175","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10545-011-9280-1","article-title":"Treatment of mucopolysaccharidosis type II (Hunter syndrome) with idursulfase: the relevance of clinical trial end points","volume":"34","author":"Glamuzina","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0180","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1203\/01.PDR.0000141987.69757.DD","article-title":"Disease-specific markers for the mucopolysaccharidoses","volume":"56","author":"Fuller","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0185","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ab.2010.04.002","article-title":"Determination of urinary noligosaccharides by high-performance liquid chromatography\/electrospray ionization-tandem mass spectrometry: Application to Hunter syndrome","volume":"402","author":"Nielsen","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0400","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymgme.2009.10.001","article-title":"Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry","volume":"99","author":"Tomatsu","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10545-009-9036-3","article-title":"Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I","volume":"33","author":"Tomatsu","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0200","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nchembio.766","article-title":"Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses","volume":"8","author":"Lawrence","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0205","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00313321","article-title":"Sanfilippo B syndrome (MPS III B): case report with analysis of CSF mucopolysaccharides and conjunctival biopsy","volume":"225","author":"Federico","year":"1981","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0210","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1373\/clinchem.2010.161141","article-title":"Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry","volume":"57","author":"Zhang","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymgme.2006.01.005","article-title":"Heparin cofactor II-thrombin complex in MPS I: a biomarker of MPS disease","volume":"88","author":"Randall","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0220","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2008.05.001","article-title":"Heparin cofactor II-thrombin complex: a biomarker of MPS disease","volume":"94","author":"Randall","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0225","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10545-010-9254-8","article-title":"Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases","volume":"34","author":"Langford-Smith","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0405","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10545-011-9369-6","article-title":"Longitudinal observations of serum heparin cofactor II-thrombin complex in treated Mucopolysaccharidosis I and II patients","volume":"35","author":"Clarke","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0235","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymgme.2009.10.175","article-title":"Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice","volume":"99","author":"Langford-Smith","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0240","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ymgme.2008.12.002","article-title":"Discovery of a new biomarker for th mucopolysaccharidoses (MPS), dipeptidyl peptidase IV (DPP-IV; CD26), by SELDI-TOF mass spectrometry","volume":"96","author":"Beesley","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0245","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1471-4159.1978.tb12388.x","article-title":"Neurochemistry of the mucopolysaccharidoses: brain lipids and lysosomal enzymes in patients with four types of mucopolysaccharidosis and in normal controls","volume":"30","author":"Constantopoulos","year":"1978","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0250","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cne.20355","article-title":"Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders","volume":"480","author":"McGlynn","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0255","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1651-2227.2007.00202.x","article-title":"Pathogenic mechanisms in lysosomal disease: a reappraisal of the role of the lysosome","volume":"96","author":"Walkley","year":"2007","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0260","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ana.20150","article-title":"Prevention of neuropathology in the mouse model of Hurler syndrome","volume":"56","author":"Desmaris","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0265","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/mt.2010.265","article-title":"Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and Hurler syndromes","volume":"19","author":"Ellinwood","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0270","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ymgme.2007.03.001","article-title":"Bone marrow transplantation for feline mucopolysaccharidosis I","volume":"91","author":"Ellinwood","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0275","doi-asserted-by":"crossref","first-page":"32157","DOI":"10.1074\/jbc.M202838200","article-title":"Separation and characterization of late endosomal membrane domains","volume":"277","author":"Kobayashi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0280","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/BJ20071043","article-title":"Effect of lysosomal storage on bis(monoacylglycero)phosphate","volume":"411","author":"Meikle","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0285","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/labinvest.3780345","article-title":"Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses","volume":"81","author":"Simonaro","year":"2001","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0290","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000156510.96253.5A","article-title":"Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models","volume":"57","author":"Simonaro","year":"2005","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0295","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","article-title":"Mechanism of glycosaminoglycan-mediated bone and joint disease: Implications for the mucopolysaccharidoses and other connective tissue diseases","volume":"172","author":"Simonaro","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0300","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1073\/pnas.0912937107","article-title":"Involvement of the Toll-like receptor 4 pathway and use of TNF-alpha antagonists for treatment of the mucopolysaccharidoses","volume":"107","author":"Simonaro","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0305","doi-asserted-by":"crossref","first-page":"e22447","DOI":"10.1371\/journal.pone.0022447","article-title":"Anti-TNF-alpha therapy enhances the effects of enzyme replacement therapy in rats with Mucopolysaccharidosis type VI","volume":"6","author":"Eliyahu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2012.05.003_bb0310","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/BA20070093","article-title":"Molecular markers for the follow-up of enzyme-replacement therapy in mucopolysaccharidosis type VI disease","volume":"49","author":"Di Natale","year":"2008","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0315","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.prrv.2010.10.005","article-title":"Respiratory manifestations in mucopolysaccharidoses","volume":"12","author":"Muhlebach","year":"2010","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0320","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00431-007-0462-7","article-title":"Abnormalities in the hair morphology of patients with some but not all types of mucopolysaccharidoses","volume":"167","author":"Czartoryska","year":"2008","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0325","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10545-011-9342-4","article-title":"Genistein supplementation in patients affected by Sanfilippo disease","volume":"34","author":"Delgadillo","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0330","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3174\/ajnr.A0510","article-title":"Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II","volume":"28","author":"Vedolin","year":"2007","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0335","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1212\/01.wnl.0000269782.80107.fe","article-title":"Brain MRI in mucopolysaccharidosis: effect of aging and correlation with biochemical findings","volume":"69","author":"Vedolin","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2012.05.003_bb0340","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3174\/ajnr.A2032","article-title":"Correlation of automated volumetric analysis of brain MR imaging with cognitive impairment in a natural history study of mucopolysaccharidosis II","volume":"31","author":"Fan","year":"2010","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0410","doi-asserted-by":"crossref","DOI":"10.1007\/s10545-010-9197-0","article-title":"Quantitative in vivo brain magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter Syndrome)","author":"Davison","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0350","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0355","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0074-7696(06)52001-7","article-title":"The biology of the Gaucher cell: the cradle of human chitinases","volume":"252","author":"Bussink","year":"2006","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0360","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1012492429191","article-title":"Clinically relevant therapeutic endpoints in type 1 Gaucher disease","volume":"24","author":"Hollak","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0365","doi-asserted-by":"crossref","first-page":"25680","DOI":"10.1074\/jbc.273.40.25680","article-title":"The human chitotriosidase gene. Nature of inherited enzyme deficiency","volume":"273","author":"Boot","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0370","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cca.2007.02.042","article-title":"Monitoring of Gaucher patients with a novel chitotriosidase assay","volume":"381","author":"Schoonhoven","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2012.05.003_bb0375","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/humu.20524","article-title":"Type 1 Gaucher disease: null and hypomorphic novel chitotriosidase mutations \u2014 implications for diagnosis and therapeutic monitoring","volume":"28","author":"Grace","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2012.05.003_bb0380","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.cca.2010.07.038","article-title":"How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?","volume":"411","author":"Auray-Blais","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2012.05.003_bb0385","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2010.03.020","article-title":"Plasma globotriaosylsphingosine as a biomarker of Fabry disease","volume":"100","author":"Togawa","year":"2010","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212001928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212001928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T12:10:03Z","timestamp":1594123803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719212001928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1096719212001928"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2012.05.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717952879.793463189","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717952879.793458367","asserted-by":"object"}]},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}